Intestine Toxicology Services Overview
Mechanism-Driven Insight for Failed Drug Candidates
Our Investigational Toxicology services use our 3D human tissue BioPrint models to investigate the underlying causes of compound-related toxicity. Tailored for projects where a drug has already shown safety concerns, this platform offers a uniquely detailed view into toxicological mechanisms using more diverse and customizable endpoints than most conventional liver and intestine models. By mimicking native human tissue structure and including a range of key cell types, the models enable insights into cellular stress, tissue damage, inflammatory signaling, and more. Clients can explore 1-2 compounds across multiple concentrations, with results delivered within 4 weeks. Whether clarifying an off-target effect, species-specific response, or organ-level failure, this service supports more informed decisions about next steps in development.


